Clinical trial NCT02934763: Opioid Induced Hyperalgesia (OIH) Modulation With Propranolol
Official title: Opioid Induced Hyperalgesia (OIH) Modulation With Propranolol, in Laparoscopic Abdominal Surgery
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: PHASE4
Conditions: Hyperalgesia
Lead sponsor: Pontificia Universidad Catolica de Chile
Sponsor class: OTHER
First posted: 2016-10-17
Enrollment: 80
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Opioid Induced Hyperalgesia (OIH) is an entity than has been demonstrated in healthy volunteers and in animal models. Is defined as an increase in the perception to painful stimuli, increasing the opioid requirements and diminishing the pain thresholds to stimuli.

The apparition of OIH is also related to the exposure to opioids during surgery, depending of the dose, the time of exposition and the type of opioid.

This condition can be modulated, specially in the perioperative context. It has been seen in healthy volunteers and in animal models, than the use of propranolol can modulate this phenomena, diminishing the postoperative requirements of analgesia. It is also unknown, the dose of propranolol required to modulate adequately OIH.

The objective of this work is to evaluate the efficacy of propranolol in the modulation of opioid induced hyperalgesia, with lower postoperative requirements of analgesia rescue.

Detailed description: This is a randomized controlled study, comparing 2 interventions with a placebo. The interventions will be use of propranolol, at different doses, to achieve specific plasmatic concentrations.

80 patients will be required to find a difference of 20% in the primary outcome.

The primary outcome to be measured is the postoperative use of opioids in the post anesthesic care unit.

Secondary outcomes, will be the amount of opioids used in the following 24 hours to the surgery, the time to the first dose of analgesia in the post anesthesic care unit, and the change in the pain thresholds, evaluated as pain by pressure and by tactile sensitivity, before and after surgery.

Also, as a secondary outcome, in a group than will not receive the study drug, we will evaluate the temporal changes in opioid induced hyperalgesia, by pain sensitivity measured in the postoperative hours 2, 4 and 24. 10 patients receiving placebo will be part of this additional measures.

Eligibility criteria: Inclusion Criteria:

* Patients scheduled for elective laparoscopic cholecystectomy
* American Society of Anesthesiology Score (ASA) I-II

Exclusion Criteria:

* Medical history of cardiac disease
* Medical history of respiratory disease
* Regular use of beta blockers
* Known allergies to drugs used in the study
* Known history of illicit drugs use

Primary outcomes:
measure: Postoperative opioid use
timeFrame: 24 hours posterior to surgery
Secondary outcomes:
measure: Pain thresholds (heat)
timeFrame: 24 hours posterior to surgery
measure: Pain thresholds (cold)
timeFrame: 24 hours posterior to surgery
measure: Pain thresholds (tactile sensitivity)
timeFrame: 24 hours posterior to surgery
measure: Temporal changes in pain sensibility
timeFrame: 24 hours posterior to surgery
Other outcomes:
Locations:
Study officials:
References: